ArticleBiomedicines2022

The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study.

Madis Parksepp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.